DNMT1 and neoplasm: A prevalent mechanism of tumor-suppressor gene inactivation in neoplastic disease is represented by transcriptional silencing by CpG island methylation, and the prototypic DNA methyltransferase, DNMT1, accounts for most methylation in mouse cells, but human cancer cells lacking DNMT1 retain significant genomic methylation and associated gene silencing [11].